Listed as “BioAge Labs”
- First observed:
- 31 Oct 2026
- Investment announced:
- Date not recorded
BioAge Labs researches therapies targeting pathways involved in metabolic aging.
BioAge Labs uses a discovery platform to study molecular mediators of aging. The platform analyzes multi-omics data, while its pipeline programs target pathways associated with metabolic aging.
Richmond, California
Location source ↗Checked
Some source history is available; coverage remains limited.
Coverage describes public evidence. Points require a qualifying milestone after your pick.
These sources establish that the firm lists the company. The observation date records when RiseFinder captured the relationship; it does not establish when the investment happened.
Listed as “BioAge Labs”
No dated funding or investment events are recorded yet. Initial portfolio listings establish the starting baseline and earn no points.